BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 18358109)

  • 21. Prurigo nodularis.
    Linhardt PW; Walling AD
    J Fam Pract; 1993 Nov; 37(5):495-8. PubMed ID: 8228862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of prurigo nodularis with lenalidomide.
    Ossorio-García L; Jiménez-Gallo D; Rodríguez-Mateos ME; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prurigo nodularis: Epidemiology and clinical features.
    Huang AH; Williams KA; Kwatra SG
    J Am Acad Dermatol; 2020 Dec; 83(6):1559-1565. PubMed ID: 32454098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prurigo nodularis of Hyde treated with low-dose thalidomide.
    Orlando A; Renna S; Cottone M
    Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
    Pereira MP; Basta S; Moore J; Ständer S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of Prurigo nodularis--'Super-Itch' in exploration.
    Zeidler C; Ständer S
    Eur J Pain; 2016 Jan; 20(1):37-40. PubMed ID: 26416433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prurigo nodularis comparative treatment outcome in patients attending a tertiary hospital in northern Tanzania.
    Mayala EV; Mavura DR; Robert M; Masenga EJ
    Dermatol Ther; 2021 Mar; 34(2):e14855. PubMed ID: 33559259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic prurigo.
    Misery L
    Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Chronic Prurigo.
    Docampo-Simón A; Sánchez-Pujol MJ; Silvestre-Salvador JF
    Actas Dermosifiliogr; 2022 Jun; 113(6):563-574. PubMed ID: 35489971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic prurigo].
    Pereira MP; Nau T; Zeidler C; Ständer S
    Hautarzt; 2018 Apr; 69(4):321-330. PubMed ID: 29568995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prurigo nodularis of Hyde: an update.
    Accioly-Filho LW; Nogueira A; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):75-82. PubMed ID: 10972090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical evaluation of nemolizumab for prurigo nodularis.
    Brooks SG; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Jun; 20(6):577-587. PubMed ID: 38217530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis.
    Gwillim EC; Nattkemper L; Yosipovitch G
    Acta Derm Venereol; 2021 Mar; 101(3):adv00424. PubMed ID: 33704503
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical classification of itch: a position paper of the International Forum for the Study of Itch.
    Ständer S; Weisshaar E; Mettang T; Szepietowski JC; Carstens E; Ikoma A; Bergasa NV; Gieler U; Misery L; Wallengren J; Darsow U; Streit M; Metze D; Luger TA; Greaves MW; Schmelz M; Yosipovitch G; Bernhard JD
    Acta Derm Venereol; 2007; 87(4):291-4. PubMed ID: 17598029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurohistological studies on the differential diagnosis of prurigo nodularis Hyde and of other forms of circumscribed lichenification].
    THIES W
    Arch Klin Exp Dermatol; 1955; 201(6):539-55. PubMed ID: 13303208
    [No Abstract]   [Full Text] [Related]  

  • 36. Dupilumab for the Treatment of Prurigo Nodularis.
    Alkhaleefa A; Woo TE; Parsons L
    Skin Therapy Lett; 2023 Nov; 28(6):7-9. PubMed ID: 38016088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prurigo nodularis: A puzzle for more than 100 years].
    Ständer S; Mettang T
    Hautarzt; 2014 Aug; 65(8):672-3. PubMed ID: 25113324
    [No Abstract]   [Full Text] [Related]  

  • 38. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
    Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
    Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
    Haas S; Capellino S; Phan NQ; Böhm M; Luger TA; Straub RH; Ständer S
    J Dermatol Sci; 2010 Jun; 58(3):193-7. PubMed ID: 20417061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethnic differences and comorbidities of 909 prurigo nodularis patients.
    Boozalis E; Tang O; Patel S; Semenov YR; Pereira MP; Stander S; Kang S; Kwatra SG
    J Am Acad Dermatol; 2018 Oct; 79(4):714-719.e3. PubMed ID: 29733939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.